Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Pandoraon Nov 20, 2024 3:41pm
41 Views
Post# 36322423

RE:RE:RE:What is next?

RE:RE:RE:What is next?
14 cents and holding -- one half a cent above the 52 week low.

Seems, according to Jopat, there is lots of peripheral news around regarding name outfits that are using VPT equipment yet it has no effect on the VPT share price. In the U.S. it is running below 10 cents.

With hospital names like the Mayo Clinic, Duke University Hospital and Phoenix Children's Hospital there should be more attention given to VPT.

I would say the information is not coming out to the benefit of Ventripoint. Do they need an IR outfit to format and spread the news in a better way?

With outfits like GE and Ascend, and a couple others, collaborating with Ventripoint, the story needs to be presented in a means that gives more embellishment to VPT. Other than that we just seem to continue skating on a wish and a prayer and it is not a successful approach -- so far, at least.

A few months ago I was kind of hoping one or two of these associated companies might give a hint of an M&A deal. Now I'm just hoping the VPT name gets mentioned in one of their news releases so that it might get us out of the basement for our share price.
<< Previous
Bullboard Posts
Next >>